Silencing CRABP2 in HCC cell lines suppresses proliferation, migration, invasion, and colony formation, while promoting apoptosis in vitro [67] with inhibition of the ERK–VEGF signalling pathway and upregulates pro-apoptotic markers such as Bax and cleaved caspase-3. Here, CRABP2 is linked to hepatocellular carcinoma.